Growth Metrics

Bioventus (BVS) Net Cash Flow (2020 - 2026)

Bioventus filings provide 6 years of Net Cash Flow readings, the most recent being $8.9 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 1465.85% to $8.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.3 million, a 29.35% increase, with the full-year FY2025 number at $9.3 million, up 29.35% from a year prior.
  • Net Cash Flow hit $8.9 million in Q4 2025 for Bioventus, down from $9.6 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $98.5 million in Q4 2022 to a low of -$108.4 million in Q4 2022.
  • Median Net Cash Flow over the past 5 years was $3.9 million (2024), compared with a mean of -$1.7 million.
  • The widest YoY moves for Net Cash Flow: up 1517.71% in 2022, down 583.78% in 2022.
  • Bioventus' Net Cash Flow stood at -$31.9 million in 2021, then crashed by 240.43% to -$108.4 million in 2022, then surged by 96.4% to -$3.9 million in 2023, then skyrocketed by 114.62% to $571000.0 in 2024, then soared by 1465.85% to $8.9 million in 2025.
  • The last three reported values for Net Cash Flow were $8.9 million (Q4 2025), $9.6 million (Q3 2025), and $9.9 million (Q2 2025) per Business Quant data.